Optimizing the Care Pathways of Patients Treated for Operable Breast.
OPTIsoins01
1 other identifier
observational
617
1 country
9
Brief Summary
This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2014
Typical duration for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
January 6, 2016
CompletedFirst Posted
Study publicly available on registry
June 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedApril 13, 2017
April 1, 2017
2.2 years
January 6, 2016
April 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Care pathways description of early breast cancer patients.
Care pathways will be characterized by the sequence of different care steps. Care steps may include : outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care.
Up to one year after patient registration
Overall cost measurements of the different care pathways.
Evaluating the overall costs of the pathway care (health care and supportive care consumption) at one year for the different perspectives.
Up to one year after patient registration
Overall cost measurements of the different care pathways for health insurance
Evaluating the indirect costs of health insurance
Up to one year after patient registration
Overall cost measurements of the different care pathways for the patient
Evaluating the out-of-pocket health expenses for breast cancer during the first year post diagnosis (direct and indirect costs).
Up to one year after patient registration
Secondary Outcomes (10)
Patient satisfaction evaluation
Up to one year after patient registration.
Supportive care needs assessement
Up to one year after patient registration
Supportive care needs assessement
Up to one year after patient registration
Breast cancer impact on patient's professional activity
Up to one year after patient registration.
Breast cancer impact on patient's professional activity
Up to one year after patient registration.
- +5 more secondary outcomes
Other Outcomes (1)
Care pathways suggestion for a regional health territory.
Through study completion (within one year after the last patient follow-up)
Eligibility Criteria
Previously untreated, operable breast cancer.
You may qualify if:
- Signed written informed consent.
- Patients aged ≥18 years.
- Previously untreated, operable breast cancer
- Affiliation with the social security system (or a similar coverage)
- Patient living in one of these french department : "Hauts-de-Seine (92)", "les Yvelines (78)", or "le Val d'Oise (95)".
- Female gender.
You may not qualify if:
- Previous history of breast cancer.
- Metastatic, locally advanced, or inflammatory breast cancer, as defined by the AJCC (American Joint Committee on Cancer, 7th Edition).
- Any prior treatment for primary breast cancer.
- Patient with any psychological, sociological or geographical condition potentially hampering compliance with the study follow-up schedule.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Curielead
Study Sites (9)
Victor Dupouy Hospital
Argenteuil, 95100, France
Antoine Béclère Hospital
Clamart, France
Louis Mourier Hospital
Colombes, 92700, France
André Mignot Hospital - Versailles
Le Chesnay, 78150, France
Institut Curie
Paris, 75005, France
Bichat Beaujon University Hospital
Paris, 75018, France
Poissy Interegional Hospital Center
Poissy, 78300, France
René Dubos Hospital
Pontoise, 95000, France
Institut Curie - René Huguenin Hospital
Saint-Cloud, 92210, France
Related Publications (1)
Arfi A, Baffert S, Soilly AL, Huchon C, Reyal F, Asselain B, Neffati S, Rouzier R, Hequet D. Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study. BMJ Open. 2018 May 18;8(5):e020276. doi: 10.1136/bmjopen-2017-020276.
PMID: 29776920DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Roman ROUZIER, Pr
Institut Curie
- STUDY DIRECTOR
Delphine HEQUET, MD PhD
Institut Curie
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2016
First Posted
June 27, 2016
Study Start
December 1, 2014
Primary Completion
February 1, 2017
Study Completion
April 1, 2017
Last Updated
April 13, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share